|
|
||||||||
1 From the Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Japan; and 2 Department of Anatomy, Yokohama City University School of Medicine, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Retinal ischemia was induced in rats by clamping the ophthalmic artery within the dural sheath of the optic nerve. Immediately after removing the clamp and beginning the reperfusion, Hsp27 protein solution was injected into the vitreous, and electroporation was applied. To determine whether Hsp27 entered the RGCs, anti-Hsp27 immunohistochemistry was performed. The retinal damage was evaluated by counting the number of RGCs retrogradely labeled by 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine percholorate (diI) injected into the superior colliculus, and also by comparing the ratio of TUNEL-positive to all RGCs in the RGC layer.
RESULTS. Electroporation successfully delivered Hsp27 protein into RGCs. In the Hsp27 electroinjected group, the number of RGCs 7 days after ischemiareperfusion was significantly higher than in the control groups. The ratio of TUNEL-positive cells to all RGCs was lower in the group electroinjected with Hsp27 protein.
CONCLUSIONS. Electroporation of Hsp27 protein into RGCs increased the resistance of the RGCs to the apoptosis induced by ischemiareperfusion injury.
| Introduction |
|---|
|
|
|---|
The purpose of this study was to determine whether electroinjection of this novel neuroprotective factor, Hsp27, into retinal ganglion cells (RGCs) after ischemiareperfusion injury, can protect the RGCs from apoptosis. We show that electroporation delivered Hsp27 to RGCs and increased the resistance of the RGCs to apoptosis in this ischemiareperfusion injury model.
| Materials and Methods |
|---|
|
|
|---|
Induction of Ischemia
Under deep anesthesia (intraperitoneal injection of a mixture of
500 mg urethane per kilogram body weight, 11 mg/kg ketamine, and 14
mg/kg xylazine), the left optic nerve was exposed by making an incision
in the upper conjunctival fornix and detaching the superior rectus
muscle. The eyeball was retracted, and the dural sheath surrounding the
optic nerve was gently cut with microscissors to separate the central
retinal artery from the nerve. The central retinal artery with the
surrounding tissue was clamped with a cerebral aneurysm surgery clip.
After 60 minutes, the clip was removed, and reperfusion of the retinal
vessels was begun. Absolute cessation and reperfusion of blood flow in
the retinal vessels was confirmed by ophthalmoscopy. Only those eyes in
which reperfusion was confirmed within 5 minutes of clip removal were
used. During these procedures, the body temperature of the rats was
maintained at 37°C.
Hsp27 Electroinjection
Immediately after the reperfusion, 5 µl Hsp27 protein
solution, containing 6.5 µg protein (StressGen Biotechnologies Corp.,
Victoria, British Columbia, Canada), was injected into the vitreous
with a 31-gauge needle. After the injection, the eye was grasped with a
forceps-type disc electrode (Forceps-Type electrode 44910PRG; Meiwa
Shoji, Tokyo, Japan). The disc on the surface of the cornea was
attached to the cathode and the disc on the sclera to the anode (Fig. 1)
. Then, square-wave pulses of 99 msec duration were administered as
follows: Five electric pulses with electric field strength of 12 V/cm
were given twice with a 5-minute interval between administrations, as
described in our previous study.7
The electro square
porator (T820; BTX, San Diego, CA) generated electric pulses at a rate
of 1 Hz. The electrical resistance of the tissue was monitored with a
graphic pulse analyzer (Optimizer 500; BTX). The mean resistance of the
eyeball was 1.69 ± 0.52 k
.
|
All rats were killed by an intracardiac perfusion of 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) under deep ether anesthesia. The retina of left eyes was removed from the eyecup, postfixed in the same fixative for 3 hours, and mounted in optimal cutting temperature (OCT) compound (Tissue Tek; Miles, Elkhart, IN). Frozen sections of 10-µm thickness were cut with a cryostat and mounted on MAS-coated microslide glass (Superfrost; Matsunami, Tokyo, Japan). These sections were stained with rabbit polyclonal antibody raised against recombinant human Hsp27 (1:200; StressGen Biotechnologies Corp.) as the primary antibody and FITC-conjugated goat antibody raised against rabbit IgG (1:1000; Antibodies Incorporated, Davis, CA) as the secondary antibody. The sections were then examined and photographed with a confocal laser microscope (Radians 2000; Bio-Rad, Hertfordshire, UK). The number of anti-Hsp27positive RGCs was counted by two masked observers in 50 retinal sections for each of the three groups of animals. In all, 100 fields for each group of rats were counted. For controls, the primary antibodies were omitted in the staining of the sections.
Count of Living RGCs 7 Days after Ischemia
To count the number of living RGCs, we applied 7 µl of the
lipophilic tracer,
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine
percholorate (diI; Molecular Probes), on the right superior
colliculus 10 days before ischemia for retrograde labeling of the RGCs
in the left eye. The diI suspension was prepared by placing 15 mg diI
in 1 ml N,N-dimethylformamide.8
DiI labeling was performed in 31 rats. Seven animals were used to determine the level of diI labeling in the normal untreated retinas. These animals were perfused with 4% paraformaldehyde in 0.1 M PBS while under deep ether anesthesia 10 days after the diI application (intact group).
Ten days after diI application, the other 24 animals underwent 60 minutes of retinal ischemia-reperfusion. In seven of these rats, Hsp27 was injected and electric pulses were administered as described (Hsp27 electroinjection group), and in five other animals, Hsp27 was injected without electric pulses (Hsp27 without-pulses group). In five animals, PBS was injected into the vitreous and electric pulses were administered (pulses group), and seven animals served as control subjects and had only ischemia (ischemia group).
Seven days after the ischemia, the animals were perfused with 4% paraformaldehyde in 0.1 M PBS under deep ether anesthesia. The retinas were taken for confocal laser microscopy (Radians 2000; Bio-Rad) within 6 hours, and the number of diI-labeled cells was counted by two masked observers. The counting was performed in 10 areas within a 1-mm radius of the optic disc because the current density from the electrodes was highest around the optic nerve.
TUNEL Staining
To demonstrate the effect of Hsp27 on preventing apoptosis in
RGCs, five animals that underwent ischemiareperfusion and had Hsp27
electroinjection and five animals with only ischemia were killed 24
hours after the beginning of reperfusion, because the peak of apoptosis
occurred 24 hours after reperfusion.
The retina of left eyes was removed from the eyecup and frozen sections were made similar to the method of immunohistochemistry. TUNEL staining was performed with an in situ apoptosis detection kit (Trevigen, Gaithersburg, MD). Labeled nuclei were then detected by streptavidin-FITC. The sections were stained with the fluorescent dye propidium iodide to label all nuclei, and the sections were studied under a fluorescence microscope (Carl Zeiss, Jena, Germany). TdT was omitted during the staining procedure as a negative control. The numbers of TUNEL-positive cells among all the cells in the RGC layers were counted by the same two masked observers in 25 frozen sections for each of the two groups of animals.
Statistical Analysis
The MannWhitney test was used to compare the number of
diI-labeled RGC in the three groups, and the ratio of TUNEL-positive
cells to all cells in the RGC layer was determined in the three groups.
In all cases, P < 0.05 was considered to be
significant and P < 0.01 was considered to be highly
significant.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Hsp27 serves as a chaperone to stabilize the cytoskeleton,12 13 and cytoskeletal breakdown is one of the key events in the initiation of apoptosis. Inhibition of protein synthesis during heat shock limits the accumulation of unfolded proteins that may damage eukaryotic cells. Chaperon Hsp27 is a heat shockinduced inhibitor of cellar protein synthesis, that binds elF4G and facilitates the dissociation of cap-binding initiation complexes known as elF4F.14
In human studies, elevated titers of serum antibodies to Hsp27 have been documented in some diseases such as cancer15 16 and glaucoma.17 The application of the antibody to Hsp27 exogenously facilitates apoptotic cell death in cultured retinal cells at concentrations similar to those found in patients with glaucoma,17 and activates a proteolytic cascade, including caspase-8 and caspase-3 activation and the cleavage of poly-(ADP ribose) polymerase.18 Hsp27 antibody enters neuronal cells in isolated human retinas by an endocytic mechanism, colocalizes with the actin cytoskeleton, and facilitates apoptotic cell death.19 These results suggest that exogenous Hsp27 antibody may induce neuronal apoptosis by inactivating or attenuating the ability of native Hsp27 to stabilize actin cytoskeleton.
There was a good correlation between the number of anti-Hsp27-labeled RGCs in the Hsp27 electroinjection group (Fig. 2A) and the number of diI-labeled RGCs in the same group, and both numbers were significantly higher than in the ischemia group. Thus, we have demonstrated that electroinjected Hsp27 protected RGCs in a rat ischemiareperfusion model for at least 7 days. We suggest that electroinjected Hsp27 inhibits RGC apoptosis by limiting the accumulation of unfolded proteins and stabilizes actin cytoskeleton.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 21, 2001; revised July 2, 2001; accepted August 6, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Akiko Yokoyama, Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba City, Chiba 260-8670, Japan. yokoyama{at}ophthalm.m.chiba-u.ac.jp
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Li, S. Roth, M. Laser, J.-x. Ma, and C. E. Crosson Retinal Preconditioning and the Induction of Heat-Shock Protein 27 Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mo, A. Yokoyama, T. Oshitari, H. Negishi, M. Dezawa, A. Mizota, and E. Adachi-Usami Rescue of Axotomized Retinal Ganglion Cells by BDNF Gene Electroporation in Adult Rats Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2401 - 2405. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |